Literature DB >> 32289858

Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis.

Elisa d'Alessandro1, Christian Becker2, Wolfgang Bergmeier3, Christoph Bode4, Joshua H Bourne5, Helena Brown6, Harry R Buller7, Arina J Ten Cate-Hoek1, Vincent Ten Cate8, Yvonne J M van Cauteren9, Yam F H Cheung10, Audrey Cleuren11, Danielle Coenen12, Harry J G M Crijns9, Ilaria de Simone12, Sophie C Dolleman13, Christine Espinola Klein14, Delia I Fernandez12, Lianne Granneman15, Arnoud van T Hof9, Peter Henke16, Yvonne M C Henskens17, Jingnan Huang12, Lisa K Jennings18, Natalie Jooss12, Mieke Karel12, Danique van den Kerkhof12, Frederik A Klok19, Bram Kremers1, Bernhard Lämmle20, Avi Leader1,21, Annika Lundstrom22, Nigel Mackman23, Pier M Mannucci24, Zahra Maqsood6, Paola E J van der Meijden1,12, Marc van Moorsel15, Luis A Moran25, John Morser26, Manouk van Mourik9, Stefano Navarro6, Raluca A I Neagoe5, Renske H Olie1, Pauline van Paridon1, Jens Posma1, Isabella Provenzale12, Pieter H Reitsma13, Billy Scaf1, Leon Schurgers12, Jaap Seelig1,27, Agneta Siegbahn28, Bob Siegerink29, Oliver Soehnlein30, Eva Maria Soriano31, Marcin A Sowa31, Henri M H Spronk1, Robert F Storey32, Chukiat Tantiwong12, Alicia Veninga12, Xueqing Wang5, Steve P Watson5, Jeff Weitz33, Sacha S Zeerleder34, Hugo Ten Cate1.   

Abstract

Thrombo-inflammation describes the complex interplay between blood coagulation and inflammation that plays a critical role in cardiovascular diseases. The third Maastricht Consensus Conference on Thrombosis assembled basic, translational, and clinical scientists to discuss the origin and potential consequences of thrombo-inflammation in the etiology, diagnostics, and management of patients with cardiovascular disease, including myocardial infarction, stroke, and peripheral artery disease. This article presents a state-of-the-art reflection of expert opinions and consensus recommendations regarding the following topics: (1) challenges of the endothelial cell barrier; (2) circulating cells and thrombo-inflammation, focused on platelets, neutrophils, and neutrophil extracellular traps; (3) procoagulant mechanisms; (4) arterial vascular changes in atherogenesis; attenuating atherosclerosis and ischemia/reperfusion injury; (5) management of patients with arterial vascular disease; and (6) pathogenesis of venous thrombosis and late consequences of venous thromboembolism. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2020        PMID: 32289858     DOI: 10.1055/s-0040-1708035

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  21 in total

Review 1.  Thrombosis and Inflammation-A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C.

Authors:  Shrey Kohli; Khurrum Shahzad; Annukka Jouppila; Harry Holthöfer; Berend Isermann; Riitta Lassila
Journal:  Front Cardiovasc Med       Date:  2022-03-31

Review 2.  COVID-19 is, in the end, an endothelial disease.

Authors:  Peter Libby; Thomas Lüscher
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 29.983

Review 3.  The cardiac complications of COVID-19: many publications, multiple uncertainties.

Authors:  Abdallah Al-Mohammad; David G Partridge; Graham Fent; Oliver Watson; Nigel T Lewis; Robert F Storey; Michael Makris; Timothy J Chico
Journal:  Vasc Biol       Date:  2020-10-20

4.  Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis.

Authors:  Ricarda D Stauss; Gerrit M Grosse; Lavinia Neubert; Christine S Falk; Danny Jonigk; Mark P Kühnel; Maria M Gabriel; Ramona Schuppner; Ralf Lichtinghagen; Mathias Wilhelmi; Karin Weissenborn; Claudia Schrimpf
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

5.  Colorectal cancer and cardiovascular disease: A thrombo-inflammatory link?

Authors:  Hugo Ten Cate
Journal:  Eur J Intern Med       Date:  2021-03-26       Impact factor: 4.487

Review 6.  Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.

Authors:  Cristina Rodríguez; Neus Luque; Isabel Blanco; Laura Sebastian; Joan Albert Barberà; Víctor I Peinado; Olga Tura-Ceide
Journal:  Am J Respir Cell Mol Biol       Date:  2021-04       Impact factor: 6.914

7.  Is COVID-19 a New Hematologic Disease?

Authors:  Benjamin Debuc; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

8.  Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

Authors:  David M Smadja; Coralie L Guerin; Richard Chocron; Nader Yatim; Jeremy Boussier; Nicolas Gendron; Lina Khider; Jérôme Hadjadj; Guillaume Goudot; Benjamin Debuc; Philippe Juvin; Caroline Hauw-Berlemont; Jean-Loup Augy; Nicolas Peron; Emmanuel Messas; Benjamin Planquette; Olivier Sanchez; Bruno Charbit; Pascale Gaussem; Darragh Duffy; Benjamin Terrier; Tristan Mirault; Jean-Luc Diehl
Journal:  Angiogenesis       Date:  2020-05-27       Impact factor: 10.658

Review 9.  COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?

Authors:  Klaus Görlinger; Daniel Dirkmann; Ajay Gandhi; Paolo Simioni
Journal:  Anesth Analg       Date:  2020-11       Impact factor: 6.627

Review 10.  Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy.

Authors:  Madhumita Chatterjee; Agnes Ehrenberg; Laura Mara Toska; Lisa Maria Metz; Meike Klier; Irena Krueger; Friedrich Reusswig; Margitta Elvers
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.